We are live on ! Find out more
SRNE

Sorrento Therapeutics, Inc.
SRNE

Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

5 hedge funds and large institutions have $826 invested in Sorrento Therapeutics, Inc. in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $704 → $826 (+$122)

29% less funds holding

Funds holding: 7 → 5 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SRNE Hedge Fund Activity: Q2 2024 in Review

5 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q2 2024, worth a combined $826 — up 17% from $704 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SRNE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 5 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q2 2024, down from 7 in Q1 2024.
  • Funds reported $826 of Sorrento Therapeutics, Inc. stock for Q2 2024, up 17% quarter-over-quarter.
  • 0 funds opened new Sorrento Therapeutics, Inc. positions in Q2 2024 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q2 2024.